Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
Published August 14, 2024 · Recall initiated: July 18, 2024
Summary
FDA records drug Class I recall D-0626-2024, published August 14, 2024 and initiated July 18, 2024. Recalling firm: MAIN PRODUCTS INC; Status: Ongoing; Reported quantity: 57, 340 bottles; Lot: All lots within expiry. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- MAIN PRODUCTS INC
- Distributor
- Nationwide within the U.S
- Lot
- All lots within expiry
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASevelamer Carbonate for Oral Suspension 0.8g packets, packaged in 90 packets per container, Distributor: Dr.August 14, 2024
- FDAAcetaminophen, USP 500mg, Pain Reliever/Fever Reducer, Extra Strength, Rapid Release Gelcaps, packaged in aAugust 14, 2024
- FDAPEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for OralAugust 14, 2024
- FDAMethotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC,August 14, 2024
- FDABD Insyte Autoguard BC, Shielded IV Catheter with Blood Control Technology, REF: 382533, 20 GA x 1.00 inAugust 7, 2024
- FDAArctic Sun Temperature Management Systems, Name/REF: Arctic Sun STAT, NA/6000-00-00; Arctic Sun STAT Loaner,August 7, 2024
Questions about this recall
Was Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles. recalled?
Yes. FDA published recall D-0626-2024 on August 14, 2024. Reported hazard: Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
What should I do if I have this product?
Voluntary: Firm initiated · Letter